Meta description: A regulatory news style overview of a VA sponsored investigational device trial in COPD pulmonary rehabilitation focusing on PEP Buddy and a sham comparator.
Publication date context: February 13, 2026. This article outlines the trial status the sponsor and the regulatory implications for clinicians and device developers without asserting results. For related updates you may read our related posts at COPD device trials in rehabilitation and Clinical trial trends in COPD devices.
In this news brief we report that a not yet recruiting study is listed for COPD using a device named PEP Buddy and a sham version. The sponsor is the VA Office of Research and Development. The source is a ClinicalTrials.gov record linked to NCT07404826.
What changed?
The listing signals a new investigational device study conducted in the COPD population undergoing pulmonary rehabilitation or rehabilitation like activities. The trial lists two study arms named PEP Buddy and PEP Buddy Sham and shows a not yet recruiting status. The sponsoring organization is the VA Office of Research and Development. No outcomes are reported in the entry; the information serves to map regulatory and development activity rather than report clinical findings.
What is PEP Buddy and what is the sham?
The record identifies the device under study as PEP Buddy and refers to a sham version named PEP Buddy Sham. Beyond the names there is no publicly detailed description of mechanism or use within this entry. The content clearly presents a randomized like framework by listing a real device and an inert sham to support comparative assessment in pulmonary rehabilitation. The entry does not provide efficacy claims or safety outcomes. Readers should rely on the formal sponsor materials and regulatory submissions for specifics.
What are the trial details and sponsor implications?
Key facts include the COPD focus the pulmonary rehabilitation context the not yet recruiting status and the sponsor source. The sponsor is the VA Office of Research and Development. The ClinicalTrials.gov record provides a single official reference for status changes. Interested clinicians regulators and device developers should monitor the listing for updates on enrollment status protocol changes and eventual results. A link to the official record is included below for precise details.
What is the trial intent?
The entry positions this work as an early stage evaluation of device assisted therapy within a rehabilitation setting. It does not claim efficacy and it is not a completed study. The status not yet recruiting indicates that enrolment has not started or is paused pending regulatory milestones or site readiness.
What are the regulatory implications for clinicians and manufacturers?
Because the study is listed as not yet recruiting an investigational device under review the regulatory considerations are preliminary. If the device advances toward enrollment and data collection these materials will inform intended use safety and performance claims. The record reflects typical regulatory language rather than a final clearance or approval. Manufacturer statements would be listed as such in the official submissions and labeling once a determination is made.
Clinicians should monitor the record through ClinicalTrials.gov and the sponsor communications for any changes in status or protocol Regulators and industry participants may use this entry to track program progress while ensuring alignment with applicable medical device regulations and rehabilitation practice standards.
What does this mean for patients and clinical practice?
At this stage the primary impact lies in the regulatory and development landscape. If future data demonstrate safety and potential benefit the device could move toward regulatory clearance and inclusion in pulmonary rehabilitation protocols. Until then clinicians should rely on established rehabilitation guidelines and await robust trial outcomes before integrating any device into routine practice The not yet recruiting status signals that patient access and reimbursement considerations will follow regulatory milestones rather than current availability.
FAQ
- What is PEP Buddy and PEP Buddy Sham This entry identifies two study arms by name only and does not provide device specifications in the record.
- What does not yet recruiting mean It indicates enrolment has not started yet and may change.
- Who sponsors the study The VA Office of Research and Development appears as the sponsor in the listing.
- Where can I find more information The official ClinicalTrials.gov record is the primary source.
- Will the device be available if the study is successful Availability depends on regulatory decisions and future approvals.
Conclusion and actions
This entry highlights an investigational device program for COPD rehabilitation under a VA sponsor Stakeholders should track enrollment status updates and protocol disclosures For clinicians contemplate how future results could affect rehabilitation practice and for device developers consider alignment with regulatory expectations as the product progresses.
Disclaimer
This article is intended for professional readers and is not legal advice It provides an overview of a clinical trial listing and regulatory considerations based on the information available in the source record.
For full information about the announcement see the link below.
https://clinicaltrials.gov/study/NCT07404826?term=medical+device